Summary
Apexor is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €63,548 and a net result of €50,043. Its solvency ranks better than 65% of 9,743 sector peers (NACE 64, financial year 2025). The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals.
History
On 4 July 2024, Apexor was incorporated as a private limited company by one natural person, with a starting capital of €100.12 Champagne, Robbe has served as eerste niet statutair bestuurder of the company since 2024.2 The company has filed 2 sets of annual accounts, the latest for financial year 2025.3
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
30-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
24-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
08-07
Gazette deed
IncorporationAppointment: Champagne, Robbe (eerste niet statutair bestuurder) · Permanent representative: Champagne, Robbe · Founder9 facts ▸
Gazette deed
Incorporation
Appointment: Champagne, Robbe (eerste niet statutair bestuurder) · Permanent representative: Champagne, Robbe · Founder9 facts ▸
- Incorporation, 03-07-2024
- Founder, Champagne, Robbe
- Founding capital, €100
- Bank account, 100, “vennootschap in oprichting” (deed in Dutch)
- Pre-incorporation commitments, “takeover, rechten en verbintenissen uit rechtshandelingen in haar naam en voor haar rekening” (deed in Dutch)
- Shareholding, 03-07-2024, 100
- Director appointment, Champagne, Robbe (eerste niet statutair bestuurder)
- Other provision, “aansprakelijkheid verbintenissen vennootschap in oprichting, tenzij vennootschap deze verbintenissen in toepassing van en binnen termijnen artikel 2:2 WVV aanva…” (deed in Dutch)
- Permanent representative, Champagne, Robbe
Gazette deedNBB filing
1 of 1 deed read